C12N 2720/10022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2720/10022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 68 US grants and 57 published applications in this corpus.
Search patents in C12N- Granted patents
- 68
- Published applications
- 57
- Assignees
- 47
- Inventors
- 162
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 7 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 0 |
| 2002 | 3 | 1 |
| 2003 | 1 | 4 |
| 2004 | 0 | 2 |
| 2005 | 1 | 3 |
| 2006 | 4 | 3 |
| 2007 | 1 | 6 |
| 2008 | 1 | 3 |
| 2009 | 4 | 3 |
| 2010 | 1 | 4 |
| 2011 | 1 | 5 |
| 2012 | 3 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 2 | 4 |
| 2018 | 2 | 2 |
| 2019 | 2 | 1 |
| 2020 | 3 | 1 |
| 2021 | 0 | 3 |
| 2022 | 3 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant herpesvirus of turkeys (HVT) and preparation method and use thereof6 Jan 2026US 12,516,353 B2Yangzhou University
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof12 Aug 2025US 12,385,068 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof30 Jan 2024US 11,883,481 B2Zoetis Services LLC
- Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof11 Oct 2022US 11,464,849 B2Zoetis Services LLC
- Recombinant turkey herpesvirus vaccines and uses thereof6 Sep 2022US 11,433,130 B2The Texas A&M University System
- Recombinant marek's disease virus and uses thereof2 Jul 2026US 2026/0183386 A1Ceva Sante Animale
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof14 Nov 2024US 2024/0374702 A1Zoetis Services LLC
- Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof1 Aug 2024US 2024/0252624 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof8 Jun 2023US 2023/0175017 A1Boehringer Ingelheim Animal Health USA Inc.
Most cited
By later US patents
- DNA-based vaccination of fish162US 5,780,448 AOttawa Civic Hospital Loeb Research · 1998
- Infectious bursal disease virus VP2 fusion protein expressed by baculovirus86US 5,605,827 AThe Ohio State University Research Foundation · 1997
- Solubilization of protein aggregates50US 4,797,474 ABunge (Australia) Pty. Ltd. · 1989
- Vaccine for immunizing fish against infectious pancreatic necrosis virus39US 5,165,925 AState of Oregon acting by and through the State Board of Higher Education on behalf of Oregon State University · 1992
- Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome34US 6,121,043 ASyntro Corporation · 2000